Shri Dadaji Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 12 Year,
- Last Filing with ROC 31 Mar 2018
- Revenue -68.72%
(FY 2018)
- Profit -92.58%
(FY 2018)
- Ebitda -123.51%
(FY 2018)
- Net Worth 0.18%
(FY 2018)
- Total Assets -0.46%
(FY 2018)
About Shri Dadaji Institute Of Medical Sciences
The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Ahuja, Narendra Ubeja, Pramod Puri, and Two other members serve as directors at the Company.
- CIN/LLPIN
U80302MP2012NPL029775
- Company No.
029775
- Company Classification
Private Not For Profit Company
- Incorporation Date
21 Dec 2012
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
East Nimar, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shri Dadaji Institute Of Medical Sciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Ahuja  | Director | 13-Mar-2015 | Current |
| Narendra Ubeja | Director | 13-Mar-2015 | Current |
| Pramod Puri | Director | 21-Dec-2012 | Current |
| Satyanarayan Maheshwari | Director | 13-Mar-2015 | Current |
| Girdhari Hinduja | Director | 21-Dec-2012 | Current |
Financial Performance of Shri Dadaji Institute Of Medical Sciences.
Shri Dadaji Institute Of Medical Sciences, for the financial year ended 2018, experienced significant reduction in revenue, with a 68.72% decrease. The company also saw a substantial fall in profitability, with a 92.58% decrease in profit. The company's net worth moved up by a moderate rise of 0.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Dadaji Institute Of Medical Sciences?
In 2018, Shri Dadaji Institute Of Medical Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Lakhanlal Anand Kumar Trade Private LimitedActive 17 years 6 months
Satyanarayan Maheshwari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shri Dadaji Institute Of Medical Sciences?
Unlock and access historical data on people associated with Shri Dadaji Institute Of Medical Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Dadaji Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Dadaji Institute Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
